Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision label in the footer changed from v3.5.4 to v3.5.5, indicating a small update to the page's versioning information in the history view.
    Difference
    0.1%
    Check dated 2026-06-05T10:38:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Record History adds a new revision entry (v3.5.4) and removes the previous v3.5.3, indicating an updated release of the page. This is a metadata update to the page version rather than a change to trial information.
    Difference
    0.1%
    Check dated 2026-05-14T22:57:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new version entry on 2026-05-01 adds the Study Status to the study's Record History, following an update on 2026-04-30 that accounted for 55 changes. A deletion on 2026-02-12 removes an earlier history entry.
    Difference
    0.2%
    Check dated 2026-05-07T20:25:49.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.3 is added to the record history, replacing the previous v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-30T16:39:25.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:07:19.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The history now shows a new Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T19:43:54.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.